Dexcom receives FDA warning letter for 2 manufacturing sites
Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...
DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter
DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...
Nasdaq5d
DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter
DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...
Becker's Hospital Review2d
FDA warns Dexcom over 2 site deficiences
Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego and ...
Fierce Biotech13h
Dexcom survey shows healthcare providers opt for CGM tech over new medications in Type 2 diabetes
A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked ...